Financial Daily from THE HINDU group of publications
Thursday, Nov 25, 2004

Cross Currency

Group Sites

Corporate - Alliances & Joint Ventures

Panacea ties up with Chiron

Our Bureau

Mumbai , Nov. 24

THE New Delhi-based Panacea Biotec Ltd has entered into a joint-venture with the UK-based Chiron Vaccines to provide new generation combination vaccines.

Chiron Panacea Vaccines, the 50:50 joint-venture company, will get operationalised on a seed capital of $1 million that has been invested by both companies, said Mr Rajesh Jain, Joint Managing Director, Panacea Biotec.

Speaking at the launch of the venture, he said that the company would kick-off with an initial portfolio of vaccines, at prices that were competitive.

"We are not saying that the vaccines will be cheap, but it will be a comprehensive combination vaccine portfolio from a single company and we are adopting a differentiation strategy to increase market-share," he said. The product portfolio largely targets the private practitioners and the vaccines will be manufactured by Panacea at it's plants in India.

More Stories on : Alliances & Joint Ventures | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
MFL to lease out biofertiliser units

New-look Grand Ashok hotel to be ready by April
SCI pays Rs 90-cr interim to Govt
Balance sheets to sport new look with revised disclosure norms
Suzlon raises Rs 100 cr
Coimbatore industrialist bags Standard Motors property
E.I.D. Parry to set up sanitaryware unit, integrated sugar complex
Panacea ties up with Chiron
Volvo may make construction equipment in India
Ford considering diesel version of Fusion — To expand dealer network
QRG targets Rs 1,000-cr turnover
Steel Secretary lauds VSP
New COO for Suven Life USA
Bhakta persuaded to reconsider resignation from Reliance board

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line